Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Neary, W.J.
Hillier, V.F.
Flute, T.
Stephens, S.D.G.
Ramsden, R.T.
and
Evans, D.G.R.
2010.
ORIGINAL ARTICLE: The relationship between patients’ perception of the effects of neurofibromatosis type 2 and the domains of the Short Form‐36.
Clinical Otolaryngology,
Vol. 35,
Issue. 4,
p.
291.
Peyre, Matthieu
Goutagny, Stephane
Imbeaud, Sandrine
Bozorg-Grayeli, Alexis
Felce, Michele
Sterkers, Olivier
and
Kalamarides, Michel
2011.
Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.
Neuro-Oncology,
Vol. 13,
Issue. 10,
p.
1125.
Ferner, Rosalie E.
2011.
Neurofibromatoses in Clinical Practice.
p.
129.
Tysome, James R.
Macfarlane, Robert
Durie-Gair, Juliette
Donnelly, Neil
Mannion, Richard
Knight, Richard
Harris, Frances
Vanat, Zebunnisa H.
Tam, Yu Chen
Burton, Katherine
Hensiek, Anke
Raymond, F. Lucy
Moffat, David A.
and
Axon, Patrick R.
2012.
Surgical Management of Vestibular Schwannomas and Hearing Rehabilitation in Neurofibromatosis Type 2.
Otology & Neurotology,
Vol. 33,
Issue. 3,
p.
466.
Szudek, Jacek
Briggs, Robert
and
Leung, Randal
2012.
Surgery for neurofibromatosis 2.
Current Opinion in Otolaryngology & Head and Neck Surgery,
Vol. 20,
Issue. 5,
p.
347.
Blakeley, Jaishri O.
Evans, D. Gareth
Adler, John
Brackmann, Derald
Chen, Ruihong
Ferner, Rosalie E.
Hanemann, C. Oliver
Harris, Gordon
Huson, Susan M.
Jacob, Abraham
Kalamarides, Michel
Karajannis, Matthias A.
Korf, Bruce R.
Mautner, Victor‐Felix
McClatchey, Andrea I.
Miao, Harry
Plotkin, Scott R.
Slattery, William
Stemmer‐Rachamimov, Anat O.
Welling, D. Bradley
Wen, Patrick Y.
Widemann, Brigitte
Hunter‐Schaedle, Kim
and
Giovannini, Marco
2012.
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.
American Journal of Medical Genetics Part A,
Vol. 158A,
Issue. 1,
p.
24.
Plotkin, Scott R.
Ardern-Holmes, Simone L.
Barker, Fred G.
Blakeley, Jaishri O.
Evans, D. Gareth
Ferner, Rosalie E.
Hadlock, Tessa A.
and
Halpin, Chris
2013.
Hearing and facial function outcomes for neurofibromatosis 2 clinical trials.
Neurology,
Vol. 81,
Issue. 21_supplement_1,
Moffat, D. A.
Lloyd, S. K. W.
Macfarlane, R.
Mannion, R.
King, A.
Rutherford, S.
Axon, P. R.
Donnelly, N.
Freeman, S.
Tysome, J. R.
Evans, D. G.
and
Ramsden, R. T.
2013.
Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2.
British Journal of Neurosurgery,
Vol. 27,
Issue. 4,
p.
446.
Tysome, James R.
Axon, Patrick R.
Donnelly, Neil P.
Evans, Dafydd Gareth
Ferner, Rosalie E.
O’Connor, Alec F. Fitzgerald
Freeman, Simon R.
Gleeson, Michael
Halliday, Dorothy
Harris, Frances
Jiang, Dan
Kerr, Richard
King, Andrew
Knight, Richard D.
Lloyd, Simon K.
Macfarlane, Robert
Mannion, Richard
Mawman, Deborah
O’Driscoll, Martin
Parry, Allyson
Ramsden, James
Ramsden, Richard
Rutherford, Scott A.
Saeed, Shakeel R.
Thomas, Nick
and
Vanat, Zebunnisa H.
2013.
English Consensus Protocol Evaluating Candidacy for Auditory Brainstem and Cochlear Implantation in Neurofibromatosis Type 2.
Otology & Neurotology,
Vol. 34,
Issue. 9,
p.
1743.
Lloyd, Simon Kingsley Wickham
Glynn, Fergal John
Rutherford, Scott Alexander
King, Andrew Thomas
Mawman, Deborah Jane
O’Driscoll, Martin Paul
Evans, Dafydd Gareth Richard
Ramsden, Richard Thomas
and
Freeman, Simon Richard Mackenzie
2014.
Ipsilateral Cochlear Implantation After Cochlear Nerve Preserving Vestibular Schwannoma Surgery in Patients With Neurofibromatosis Type 2.
Otology & Neurotology,
Vol. 35,
Issue. 1,
p.
43.
Tysome, James R.
Axon, Patrick R.
Donnelly, Neil P.
Durie-Gair, Juliette
Gareth Evans, D.
Ferner, Rosalie E.
Macfarlane, Robert
Mannion, Richard
Nduka, Charles
Morris, Katrina
Pretorius, Pieter M.
Rands, Gabriella
Rowe, Jeremy
and
Taylor, Amy
2014.
Current Concepts in Management of Vestibular Schwannomas in Neurofibromatosis Type 2.
Current Otorhinolaryngology Reports,
Vol. 2,
Issue. 4,
p.
248.
Walton, Joanna
Donnelly, Neil P.
Tam, Yu Chuen
Joubert, Ilse
Durie-Gair, Juliette
Jackson, Cay
Mannion, Richard A.
Tysome, James R.
Axon, Patrick R.
and
Scoffings, Daniel J.
2014.
MRI Without Magnet Removal in Neurofibromatosis Type 2 Patients With Cochlear and Auditory Brainstem Implants.
Otology & Neurotology,
Vol. 35,
Issue. 5,
p.
821.
Aboukais, Rabih
Zairi, Fahed
Bonne, Nicolas-Xavier
Baroncini, Marc
Schapira, Stéphane
Vincent, Christophe
and
Lejeune, Jean-Paul
2015.
Causes of mortality in neurofibromatosis type 2.
British Journal of Neurosurgery,
Vol. 29,
Issue. 1,
p.
37.
Cosetti, Maura K.
Golfinos, John G.
and
Roland, J. Thomas
2015.
Quality of Life (QoL) Assessment in Patients with Neurofibromatosis Type 2 (NF2).
Otolaryngology–Head and Neck Surgery,
Vol. 153,
Issue. 4,
p.
599.
Mahboubi, Hossein
Maducdoc, Marlon M.
Yau, Amy Y.
Ziai, Kasra
Ghavami, Yaser
Badran, Karam W.
Al‐Thobaiti, Majid
Brandon, Bryan
and
Djalilian, Hamid R.
2015.
Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
Otolaryngology–Head and Neck Surgery,
Vol. 153,
Issue. 5,
p.
822.
Lloyd, S.K.W.
King, A.T.
Rutherford, S.A.
Hammerbeck‐Ward, C.L.
Freeman, S.R.M.
Mawman, D.J.
O'Driscoll, M.
and
Evans, D.G.
2017.
Hearing optimisation in neurofibromatosis type 2: A systematic review.
Clinical Otolaryngology,
Vol. 42,
Issue. 6,
p.
1329.
Talaei-Khoei, Mojtaba
Riklin, Eric
Merker, Vanessa L.
Sheridan, Monica R.
Jordan, Justin T.
Plotkin, Scott R.
and
Vranceanu, Ana-Maria
2017.
First use of patient reported outcomes measurement information system (PROMIS) measures in adults with neurofibromatosis.
Journal of Neuro-Oncology,
Vol. 131,
Issue. 2,
p.
413.
Harris, Frances
Tysome, James R.
Donnelly, Neil
Durie-Gair, Juliette
Crundwell, Gemma
Tam, Yu Chuen
Knight, Richard D
Vanat, Zebunnisa H.
Folland, Nicola
and
Axon, Patrick
2017.
Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Cochlear Implants International,
Vol. 18,
Issue. 3,
p.
171.
Iwatate, Kensho
Yokoo, Takeshi
Iwatate, Eriko
Ichikawa, Masahiro
Sato, Taku
Fujii, Masazumi
Sakuma, Jun
and
Saito, Kiyoshi
2017.
Population Characteristics and Progressive Disability in Neurofibromatosis Type 2.
World Neurosurgery,
Vol. 106,
Issue. ,
p.
653.
Merker, Vanessa L.
McDannold, Sarah
Riklin, Eric
Talaei-Khoei, Mojtaba
Sheridan, Monica R.
Jordan, Justin T.
Plotkin, Scott R.
and
Vranceanu, Ana-Maria
2018.
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.
Journal of Neuro-Oncology,
Vol. 136,
Issue. 2,
p.
335.